LENZ Therapeutics LENZ
NASDAQ LENZ
$3.84 -0.02 (-0.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Current Deferred Revenue (2026)

Updated

LENZ Therapeutics (LENZ) posted Current Deferred Revenue of $785,000 for Q2 2026.

Analysis

LENZ Therapeutics (LENZ) Current Deferred Revenue (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 LENZ Therapeutics 120.64 Mn 120.64 Mn 5.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 785,000.00
API Access

LENZ Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LENZ&period=max&api_key=YOUR_API_KEY